SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 116 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2014. The put-call ratio across all filers is 2.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $15,440,000 | +30.4% | 158,319 | +24.0% | 0.01% | +28.6% |
| Q4 2014 | $11,844,000 | +40.4% | 127,652 | +4.1% | 0.01% | +40.0% |
| Q3 2014 | $8,435,000 | -34.4% | 122,641 | -0.0% | 0.01% | -37.5% |
| Q2 2014 | $12,854,000 | +36.7% | 122,658 | +8.2% | 0.01% | +33.3% |
| Q1 2014 | $9,402,000 | +46.8% | 113,327 | +14.5% | 0.01% | +50.0% |
| Q4 2013 | $6,405,000 | +14.9% | 98,979 | +12.4% | 0.00% | 0.0% |
| Q3 2013 | $5,576,000 | +157.9% | 88,072 | +71.1% | 0.00% | +100.0% |
| Q2 2013 | $2,162,000 | – | 51,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|